These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37130467)

  • 21. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study.
    Hill ML; Loflin M; Nichter B; Norman SB; Pietrzak RH
    Addict Behav; 2021 Sep; 120():106963. PubMed ID: 33964583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians.
    Copeland WE; Hill S; Costello EJ; Shanahan L
    J Am Acad Child Adolesc Psychiatry; 2017 Feb; 56(2):124-132.e2. PubMed ID: 28117058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Item response theory analysis of lifetime cannabis-use disorder symptom severity in an American Indian community sample.
    Gilder DA; Lau P; Ehlers CL
    J Stud Alcohol Drugs; 2009 Nov; 70(6):839-49. PubMed ID: 19895760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of the Cannabis Abuse Screening Test (CAST) in the general population.
    Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F
    Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities.
    Boyd CJ; Veliz PT; McCabe SE
    Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867
    [No Abstract]   [Full Text] [Related]  

  • 26. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study.
    Feingold D; Livne O; Rehm J; Lev-Ran S
    Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults.
    Annaheim B; Rehm J; Gmel G
    Eur Addict Res; 2008; 14(4):190-7. PubMed ID: 18583916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample.
    Adamson SJ; Sellman JD
    Drug Alcohol Rev; 2003 Sep; 22(3):309-15. PubMed ID: 15385225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
    Hayley AC; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
    Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
    JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization.
    Ecker AH; Lang B; Hogan J; Cucciare MA; Lindsay J
    J Subst Abuse Treat; 2020 Feb; 109():46-49. PubMed ID: 31856950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization.
    Hill ML; Nichter BM; Norman SB; Loflin M; Pietrzak RH
    J Affect Disord; 2021 Jan; 278():528-535. PubMed ID: 33017681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation.
    Richards DK; Schwebel FJ; Sotelo M; Pearson MR;
    Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts.
    Bryan JL; Hogan J; Lindsay JA; Ecker AH
    J Subst Abuse Treat; 2021 Mar; 122():108254. PubMed ID: 33509412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered amygdala-cortical connectivity in individuals with Cannabis use disorder.
    Aloi J; McCusker MC; Lew BJ; Schantell M; Eastman JA; Frenzel MR; Wilson TW
    J Psychopharmacol; 2021 Nov; 35(11):1365-1374. PubMed ID: 34730052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revising the Cannabis Use Disorders Identification Test (CUDIT) by means of Item Response Theory.
    Annaheim B; Scotto TJ; Gmel G
    Int J Methods Psychiatr Res; 2010 Sep; 19(3):142-55. PubMed ID: 20812291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition.
    Mills L; Lintzeris N; O'Malley M; Arnold JC; McGregor IS
    Drug Alcohol Rev; 2022 Jul; 41(5):1095-1108. PubMed ID: 35172040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide DNA methylation analysis of cannabis use disorder in a veteran cohort enriched for posttraumatic stress disorder.
    Garrett ME; Dennis MF; Bourassa KJ; ; Hauser MA; Kimbrel NA; Beckham JC; Ashley-Koch AE
    Psychiatry Res; 2024 Mar; 333():115757. PubMed ID: 38309009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nondisordered Cannabis Use Among US Adolescents.
    Sultan RS; Zhang AW; Olfson M; Kwizera MH; Levin FR
    JAMA Netw Open; 2023 May; 6(5):e2311294. PubMed ID: 37133862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.